Methodology

All entries for: Cellenkos Inc

October 17, 2025

Cellenkos Inc

Orphan Drug Designation

FDA orphan drug designation: treatment of amyotrophic lateral sclerosis

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top